Investigators assessed the effectiveness of intravenous ibandronate on bone mineral density in patients with osteoporosis who did not respond to oral bisphosphonates.
Bone attenuation was found to be an independent determinant for vertebral fractures in former smokers with and without chronic obstructive pulmonary disease.
Glucocorticoid therapy was linked to significant bone deficits across multiple axial sites, regardless of disease activity.
MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of FractureOctober 01, 2018
Findings suggest potential pathomechanistic links between miRNAs and cortical porosity. .
In postmenopausal women who were randomly assigned anastrozole, bone mineral density showed significant improvement at the lumbar spine.
Investigators sought to determine the effects of vitamin D3 supplementation in postmenopausal women with low serum 25(OH)D and high parathyroid hormone levels.
Early life exposures, such as maternal smoking and breastfeeding, may have effects on bone mineral density in young adulthood.
Bisphosphonate holidays of 3 to 5 years have been recommended as a means of achieving the antifracture benefit of the medication.
Endocrinology Advisor Articles
- Fasting Glycemic Variability Indicates Increased Risk for Type 2 Diabetes
- Heritability of BMI Stronger in Obesogenic Environments
- Adverse Events Associated With Diazoxide Treatment for Congenital Hyperinsulinism
- Maternal Gluten Intake Associated With Risk for Type 1 Diabetes in Offspring
- Domestic Refrigeration May Pose Underestimated Risk for Insulin Quality
- Vitamin D Supplementation Has No Effect on Musculoskeletal Health
- Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy
- Industry-Funded Trials Often Involve Employees in Studies
- Nutrition Tips for Physicians: Staying Healthy During Busy Days
- Early-Onset Asthma/Wheezing Associated With Later Childhood Obesity